INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,374 | $7.41 | 13,904 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 3,374 | $7.91 | 10,530 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,626 | $7.41 | 12,156 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 1,626 | $7.91 | 10,530 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,500 | -- | 11,874 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,000 | -- | 6,874 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,500 | -- | 3,374 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,374 | -- | -- |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,500 | -- | 13,500 |
| Oct 08, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,500 | -- | 12,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.